Eleonora Calabretta

Years Active: 2021-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Eleonora Calabretta, Martina di Trani, Francesco Corrado, Martina Sollini, Vanessa Cristaldi, Fabrizio Marino, Lodovico Terzi di Bergamo, Alessio Bruscaggin, Maria Cristina Pirosa, Stefania Bramanti, Arturo Chiti, Davide Rossi, Carmello Carlo-Stella
Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma. British journal of haematology (2023)
Eleonora Calabretta, Mehdi Hamadani, Pier Luigi Zinzani, Paolo Caimi, Carmello Carlo-Stella
The antibody-drug conjugate loncastuximab tesirine for the treatment of diffuse large B-cell lymphoma. Blood 140 (4) (2022)
Eleonora Calabretta, Anna Guidetti, Francesca Ricci, Martina Di Trani, Chiara Monfrini, Massimo Magagnoli, Stefania Bramanti, Davide Maspero, Lucia Morello, Michele Merli, Alice Di Rocco, Alex Graudenzi, Enrico Derenzini, Marco Antoniotti, Davide Rossi, Paolo Corradini, Armando Santoro, Carmello Carlo-Stella
Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics. British journal of haematology 198 (1) (2022)
Eleonora Calabretta, Jose M Moraleda, Massimo Iacobelli, Ruben Jara, Israel Vlodavsky, Peter O'Gorman, Antonio Pagliuca, Clifton Mo, Rebecca M Baron, Alessio Aghemo, Robert Soiffer, Jawed Fareed, Carmello Carlo-Stella, Paul Richardson
COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies. British journal of haematology 193 (1) (2021)

Eleonora Calabretta.css-eqlu8i{font-size:small;padding-left:4px;}